
Researcher Philip Britz-McKibbin in his lab. (Photo by JD Howell.)
Scientists at McMaster University have discovered several new biomarkers from a single drop of blood that could allow earlier and more definitive detection of cystic fibrosis (CF), a genetic disease which strikes both children and adults, causing chronic problems with the digestive system and the lungs.
The findings, published online in the Journal of Proteome Research, are significant because current newborn screening methods are not accurate enough to identify the disorder in the population, which can manifest itself in many different ways, requiring additional testing and causing further stress for anxious parents.
“The earlier CF is detected, the earlier it can be managed and treated, which means better health outcomes for affected infants, including their future growth and development,” says Philip Britz-McKibbin, lead author of the study and a professor in McMaster’s Department of Chemistry & Chemical Biology, who conducted the research with graduate student Alicia DiBattista, now a postdoctoral fellow at Newborn Screening Ontario (NSO).
A tiny amount of blood is drawn from the heel of all babies as part of universal newborn screening programs that test for many rare yet treatable diseases since babies usually have no signs of disease at birth, including CF.
In the case of CF, infants are screened for a pancreatic enzyme and then a panel of disease-causing genetic mutations associated with CF. However, further testing to confirm or rule out the disease finds that most babies who screen-positive do not actually have the disease. These babies are later found to be “healthy carriers” or their results are deemed to be “false positives”.
With this in mind, researchers set out to determine whether they could discover chemical signatures in a dried blood spot that could better distinguish infants who have CF from those who do not.
Using less than a single drop of blood stored at NSO at CHEO, a pediatric health and research centre in Ottawa, researchers analyzed and compared samples from infants confirmed to have CF with the samples of both healthy and screen positive infants. They found several new compounds as well as simple amino acids directly related to affected infants with CF who otherwise have no symptoms and normal birth weight.
“These biomarkers provide new insights into the disease process early in life before symptoms are fully apparent,” says Britz-McKibbin. “Moreover, these compounds can be analyzed by mass spectrometry at incremental costs since it is already used for testing many other genetic diseases at newborn screening facilities around the world”
“Ontario started screening for Cystic Fibrosis in April 2007, and since that time over 400 children have already benefited from early recognition and early treatment. But for every one of these children, about 10 have had a false-positive result. We want to get this number down and are very hopeful that the new biomarkers discovered by this research project will help us do exactly that,” says Pranesh Chakraborty, medical director of NSO at CHEO.
In Canada, life expectancy rates have risen dramatically with the median age of survival now over 50 years, due to better treatments to improve lung function, better nutrition, lung transplants. The advent of universal newborn screening programs for CF will likely further improve the quality of life of affected patients.
“We know that early detection can have significant benefits for people living with cystic fibrosis,” said Dr. John Wallenburg, chief scientific officer at Cystic Fibrosis Canada. “The current screening methodologies capture a broad swathe of families that then need further testing to narrow down those that are true positives. The anxiety and distress that such further testing can needlessly cause families was a major concern that slowed the adoption of newborn screening in some jurisdictions. Dr. Britz-McKibbin’s data provide insights for more specific newborn screening, as well as early manifestations of the disease.”
Learn more: Identifying cystic fibrosis earlier and more reliably
The Latest on: Cystic fibrosis
via Google News
The Latest on: Cystic fibrosis
- How bacteria defeat cystic fibrosis drugson February 27, 2021 at 4:53 pm
Researchers have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic fibrosis.Cystic fibrosis is a ...
- Bacteria use slimy strategy to defeat antibiotics that fight cystic fibrosison February 27, 2021 at 2:47 am
University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic ...
- Research reveals how bacteria defeat drugs that fight cystic fibrosison February 26, 2021 at 11:46 am
University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic ...
- A rabbit model of cystic fibrosison February 26, 2021 at 8:41 am
Existing animal models (zebrafish, flies, mice, rats, ferrets, sheep and pigs) of cystic fibrosis (CF) have greatly contributed to our understanding of CF pathophysiology, despite inherent limitations ...
- Access to cystic fibrosis drug would save lives, says Nova Scotia womanon February 26, 2021 at 2:00 am
A Nova Scotia woman with cystic fibrosis says she has contemplated moving to Europe in a desperate attempt to gain access to a drug that is being hailed as a breakthrough.
- Cystic fibrosis: Life-saving Trikafta drugmaker announces it will submit Medsafe application, in talks with Pharmacon February 26, 2021 at 12:42 am
It's great news for young Kiwi Izaeah Twose, who's been relying lately on the kindness of strangers to stay alive.
- Global Cystic Fibrosis Market Size 2021 Top Manufacturers, Share, Growth Factor, Latest Trends, Type and Application Forecast 2026on February 23, 2021 at 1:06 am
Global “Cystic Fibrosis Market” report is a fact-based market research and important information to companies, ...
- How do patients with cystic fibrosis respond to COVID-19?on February 22, 2021 at 8:13 am
Based on clinical data, patients with cystic fibrosis (CF) don't appear to be especially susceptible to COVID-19, and when they do get infected, they don't seem to get sicker. But Ruobing (Ruby) Wang, ...
- Registration open for 30-day fitness challenge benefiting those with cystic fibrosison February 20, 2021 at 11:45 am
For most of us, taking a deep breath of fresh air is one of the simple pleasures in life. Fresh air fills our lungs as we inhale and leaves our ...
- Cystic Fibrosis and COVID-19on February 16, 2021 at 1:31 pm
People with cystic fibrosis, or CF, don’t appear to be especially susceptible to COVID-19, and when they do get infected, they don’t seem to get sicker, based on clinical data so far. But Ruobing ...
via Bing News